166 related articles for article (PubMed ID: 38657999)
1. Photobiomodulation in the treatment of palmar-plantar erythrodysesthesia: a randomised controlled clinical study protocol.
Lestido V; Rodríguez F; Rodríguez A; Pombo V; Barrios R; Pavani C
BMJ Open; 2024 Apr; 14(4):e081459. PubMed ID: 38657999
[TBL] [Abstract][Full Text] [Related]
2. A pilot randomized double-blind, placebo-controlled study on the effects of the topical application of pyridoxine on palmar-plantar erythrodysesthesia (PPE) induced by capecitabine or pegylated liposomal doxorubicin (PLD).
Charalambous A; Tsitsi T; Astras G; Paikousis L; Filippou E
Eur J Oncol Nurs; 2021 Feb; 50():101866. PubMed ID: 33227569
[TBL] [Abstract][Full Text] [Related]
3. Amber photobiomodulation versus tranexamic acid for the treatment of melasma: protocol for a double-blind, randomised controlled trial.
Galache TR; Galache M; Sena MM; Pavani C
BMJ Open; 2023 Jul; 13(7):e073568. PubMed ID: 37479524
[TBL] [Abstract][Full Text] [Related]
4. Treatment of palmar-plantar erythrodysesthesia (PPE) with topical sildenafil: a pilot study.
Meadows KL; Rushing C; Honeycutt W; Latta K; Howard L; Arrowood CA; Niedzwiecki D; Hurwitz HI
Support Care Cancer; 2015 May; 23(5):1311-9. PubMed ID: 25341548
[TBL] [Abstract][Full Text] [Related]
5. Study protocol for the use of photobiomodulation with red or infrared LED on waist circumference reduction: a randomised, double-blind clinical trial.
Marreira M; Rocha Mota L; Silva DFT; Pavani C
BMJ Open; 2020 Aug; 10(8):e036684. PubMed ID: 32784257
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of photobiomodulation on oral lichen planus: a protocol study for a double-blind, randomised controlled clinical trial.
Ferri EP; Gallo CB; Abboud CS; Yanaguizawa WH; Horliana ACRT; Silva DFTD; Pavani C; Bussadori SK; Nunes FD; Mesquita-Ferrari RA; Fernandes KPS; Rodrigues MFSD
BMJ Open; 2018 Oct; 8(10):e024083. PubMed ID: 30297352
[TBL] [Abstract][Full Text] [Related]
7. Use of low-level laser therapy (LLLT) or photobiomodulation (PBM) for the management of the hand-foot syndrome (HSF) or palmo-plantar erythrodysesthesia (PPED) associated with cancer therapy.
Latifyan S; Genot MT; Fernez B; Scharll MF; Klastersky JA
Support Care Cancer; 2020 Jul; 28(7):3287-3290. PubMed ID: 31754836
[TBL] [Abstract][Full Text] [Related]
8. Accelerated versus standard epirubicin followed by cyclophosphamide, methotrexate, and fluorouracil or capecitabine as adjuvant therapy for breast cancer in the randomised UK TACT2 trial (CRUK/05/19): a multicentre, phase 3, open-label, randomised, controlled trial.
Cameron D; Morden JP; Canney P; Velikova G; Coleman R; Bartlett J; Agrawal R; Banerji J; Bertelli G; Bloomfield D; Brunt AM; Earl H; Ellis P; Gaunt C; Gillman A; Hearfield N; Laing R; Murray N; Couper N; Stein RC; Verrill M; Wardley A; Barrett-Lee P; Bliss JM;
Lancet Oncol; 2017 Jul; 18(7):929-945. PubMed ID: 28600210
[TBL] [Abstract][Full Text] [Related]
9. A randomised controlled feasibility trial to evaluate Lawsonia inermis (henna)'s effect on palmar-plantar erythrodysesthesia induced by capecitabine or pegylated liposomal doxorubicin.
Stavrinou M; Tsitsi T; Astras G; Paikousis L; Charalambous A
Eur J Oncol Nurs; 2021 Apr; 51():101908. PubMed ID: 33626423
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of oral administration of cystine and theanine in patients with colorectal cancer undergoing capecitabine-based adjuvant chemotherapy after surgery: study protocol for a multi-institutional, randomised, double-blinded, placebo-controlled, phase II trial.
Hamaguchi R; Tsuchiya T; Miyata G; Sato T; Takahashi K; Ariyoshi K; Oyamada S; Iwase S
BMJ Open; 2018 Jul; 8(7):e021442. PubMed ID: 30030317
[TBL] [Abstract][Full Text] [Related]
11. An exploratory study to identify risk factors for the development of capecitabine-induced Palmar Plantar Erythrodysesthesia (PPE).
Law A; Dyson S; Anthony D
J Adv Nurs; 2015 Aug; 71(8):1825-32. PubMed ID: 25702709
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of photobiomodulation therapy combined with mobile health education in patients with head and neck cancer suffering from chronic xerostomia after radiotherapy: protocol for a three-arm, randomised, placebo-controlled, double-blinded study.
Lopez-Garzon M; López-Fernández MD; Ruíz-Martínez AM; Galván-Banqueri P; Lozano-Lozano M; Tovar-Martín I; Postigo-Martin P; Ariza-Vega P; Artacho-Cordón F; Fernández-Lao C; Cantarero-Villanueva I; Fernández-Gualda MÁ; Arroyo-Morales M; Ruíz-Villaverde R; Galiano-Castillo N
BMJ Open; 2024 Jan; 14(1):e078068. PubMed ID: 38267245
[TBL] [Abstract][Full Text] [Related]
13. Sensory-motor and cardiorespiratory sensory rehabilitation associated with transcranial photobiomodulation in patients with central nervous system injury: Trial protocol for a single-center, randomized, double-blind, and controlled clinical trial.
Pinto AP; Guimarães CL; Souza GADS; Leonardo PS; Neves MFD; Lima FPS; Lima MO; Lopes-Martins RAB
Medicine (Baltimore); 2019 Jun; 98(25):e15851. PubMed ID: 31232920
[TBL] [Abstract][Full Text] [Related]
14. Prevention of palmar-plantar erythrodysesthesia with an antiperspirant in breast cancer patients treated with pegylated liposomal doxorubicin (SAKK 92/08).
Templeton AJ; Ribi K; Surber C; Sun H; Hsu Schmitz SF; Beyeler M; Dietrich D; Borner M; Winkler A; Müller A; von Rohr L; Winterhalder RC; Rochlitz C; von Moos R; Zaman K; Thürlimann BJ; Ruhstaller T;
Breast; 2014 Jun; 23(3):244-9. PubMed ID: 24656636
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of the effects of photobiomodulation on orthodontic movement of molar verticalization with mini-implant: A randomized double-blind protocol study.
Murakami-Malaquias-Silva F; Rosa EP; Almeida PA; Schalch TO; Tenis CA; Negreiros RM; Horliana RF; Garcez AS; Fernandes MUR; Tortamano A; Motta LJ; Bussadori SK; Horliana ACRT
Medicine (Baltimore); 2020 Mar; 99(13):e19430. PubMed ID: 32221067
[TBL] [Abstract][Full Text] [Related]
16. A randomized, double-blind, placebo-controlled phase III clinical trial to evaluate the efficacy and safety of SARS-CoV-2 vaccine (inactivated, Vero cell): a structured summary of a study protocol for a randomised controlled trial.
Akova M; Unal S
Trials; 2021 Apr; 22(1):276. PubMed ID: 33849629
[TBL] [Abstract][Full Text] [Related]
17. Palmar-plantar erythrodysesthesia (PPE): a literature review with commentary on experience in a cancer centre.
Webster-Gandy JD; How C; Harrold K
Eur J Oncol Nurs; 2007 Jul; 11(3):238-46. PubMed ID: 17350337
[TBL] [Abstract][Full Text] [Related]
18. A randomised, double-blind, placebo-controlled, pilot trial of intravenous plasma purified alpha-1 antitrypsin for SARS-CoV-2-induced Acute Respiratory Distress Syndrome: a structured summary of a study protocol for a randomised, controlled trial.
McEvoy NL; Clarke JL; Mc Elvaney OJ; Mc Elvaney OF; Boland F; Hyland D; Geoghegan P; Donnelly K; Friel O; Cullen A; Collins AM; Fraughen D; Martin-Loeches I; Hennessy M; Laffey JG; Mc Elvaney NG; Curley GF
Trials; 2021 Apr; 22(1):288. PubMed ID: 33874981
[TBL] [Abstract][Full Text] [Related]
19. Comparison of the effects of 2 frequencies of application of photobiomodulation on facial rejuvenation: Controlled, randomized, and double-blind clinical trial.
Bragato EF; Pires JA; Momolli M; Guerra MB; Paisano AF; Ferrari RAM; Bussadori SK; Motta LJ; Fernandes KPS
Medicine (Baltimore); 2023 Feb; 102(5):e32514. PubMed ID: 36749255
[TBL] [Abstract][Full Text] [Related]
20. Palmar-plantar erythrodysesthesia associated with capecitabine chemotherapy: a case report.
Kigen G; Busakhala N; Njiru E; Chite F; Loehrer P
Pan Afr Med J; 2015; 21():228. PubMed ID: 26523170
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
